Fed Circ affirms Eli Lilly victories over cancer drugs

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta (pemetrexed).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Eli Lilly seals $1bn genetics deal

17 December 2020 Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

Americas

SCOTUS refuses to hear Eli Lilly patent win

16 June 2020 The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.

Big Pharma

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18 December 2019 US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.

More on this story

Americas

Eli Lilly seals $1bn genetics deal

17 December 2020 Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

Americas

SCOTUS refuses to hear Eli Lilly patent win

16 June 2020 The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.

Big Pharma

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18 December 2019 US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.

More on this story

Americas

Eli Lilly seals $1bn genetics deal

17 December 2020 Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

Americas

SCOTUS refuses to hear Eli Lilly patent win

16 June 2020 The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.

Big Pharma

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18 December 2019 US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.